G01N 2333/90245
Acting on paired donors with incorporation of molecular oxygen
Official title: acting on paired donors with incorporation of molecular oxygen (1.14)
G01N2333/90245 (Acting on paired donors with incorporation of molecular oxygen) appears on 174 US grants and 347 published applications in this corpus.
Search patents in G01N- Granted patents
- 174
- Published applications
- 347
- Assignees
- 229
- Inventors
- 674
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 4 | 5 |
| 2002 | 6 | 10 |
| 2003 | 6 | 25 |
| 2004 | 5 | 16 |
| 2005 | 4 | 16 |
| 2006 | 7 | 14 |
| 2007 | 8 | 13 |
| 2008 | 7 | 11 |
| 2009 | 5 | 12 |
| 2010 | 9 | 18 |
| 2011 | 8 | 15 |
| 2012 | 3 | 9 |
| 2013 | 8 | 11 |
| 2014 | 11 | 20 |
| 2015 | 7 | 26 |
| 2016 | 15 | 23 |
| 2017 | 8 | 15 |
| 2018 | 6 | 17 |
| 2019 | 4 | 8 |
| 2020 | 5 | 7 |
| 2021 | 1 | 19 |
| 2022 | 7 | 4 |
| 2023 | 7 | 6 |
| 2024 | 6 | 13 |
| 2025 | 4 | 9 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Diagnosis, prognosis and treatment of malignant neoplasms29 Sep 2026US 12,748,114 B2Rhode Island Hospital
- Antibody for detecting acetylation of COX2 protein, and uses thereof5 May 2026US 12,618,840 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Method and agents for detecting luciferase activity18 Nov 2025US 12,473,582 B2Light Bio, Inc.
- Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising COX2 acetylating agent as active ingredient26 Aug 2025US 12,399,184 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Composition for diagnosing diseases associated with COX2 overexpression and screening method therefor17 Jun 2025US 12,332,244 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Methods and compositions for modification and detection of 5-methylcytosine3 Sep 2026US 2026/0258487 A1The University of Chicago
- Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose27 Aug 2026US 2026/0251655 A1PAM Theragnostics GmbH
- Method of predicting success of a cancer therapy13 Aug 2026US 2026/0235610 A1Immusmol SAS
- 13-cis retinoic acid and neurodevelopment disorders21 May 2026US 2026/0139288 A1
- Therapeutic agent for treating hif-1alpha-mediated diseases by inhibiting arel1 and restoring phd2 activity7 May 2026US 2026/0125685 A1Biochemgen Inc.
Most cited
By later US patents
- Relative rates of cytochrome p450 metabolism31US 6,625,547 B1ArQule, Inc. · 2003
- Pharmaceuticals and methods for treating hypoxia and screening methods therefor24US 6,855,510 B2Dana-Farber Cancer Institute, Inc. · 2005
- Muteins of hypoxia inducible factor alpha and methods of use thereof22US 6,849,718 B2Dana-Farber Cancer Institute, Inc. · 2005
- Luminescence-based methods and probes for measuring cytochrome P450 activity22US 7,692,022 B2Promega Corporation · 2010
- Methods useful for vitamin D deficiency and related disorders21US 8,962,239 B2Opko IP Holdings II, Inc. · 2015